502 related articles for article (PubMed ID: 18419306)
1. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
[TBL] [Abstract][Full Text] [Related]
2. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
[TBL] [Abstract][Full Text] [Related]
3. Circadian disruption in experimental cancer processes.
Filipski E; Lévi F
Integr Cancer Ther; 2009 Dec; 8(4):298-302. PubMed ID: 20042408
[TBL] [Abstract][Full Text] [Related]
4. Circadian timing in cancer treatments.
Lévi F; Okyar A; Dulong S; Innominato PF; Clairambault J
Annu Rev Pharmacol Toxicol; 2010; 50():377-421. PubMed ID: 20055686
[TBL] [Abstract][Full Text] [Related]
5. The days and nights of cancer cells.
Canaple L; Kakizawa T; Laudet V
Cancer Res; 2003 Nov; 63(22):7545-52. PubMed ID: 14633665
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic jet lag on tumor progression in mice.
Filipski E; Delaunay F; King VM; Wu MW; Claustrat B; Gréchez-Cassiau A; Guettier C; Hastings MH; Francis L
Cancer Res; 2004 Nov; 64(21):7879-85. PubMed ID: 15520194
[TBL] [Abstract][Full Text] [Related]
7. Circadian clocks: neural and peripheral pacemakers that impact upon the cell division cycle.
Reddy AB; Wong GK; O'Neill J; Maywood ES; Hastings MH
Mutat Res; 2005 Jul; 574(1-2):76-91. PubMed ID: 15914209
[TBL] [Abstract][Full Text] [Related]
8. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day.
Yang X; Wood PA; Ansell CM; Quiton DF; Oh EY; Du-Quiton J; Hrushesky WJ
Chronobiol Int; 2009 Oct; 26(7):1323-39. PubMed ID: 19916834
[TBL] [Abstract][Full Text] [Related]
9. Daily coordination of cancer growth and circadian clock gene expression.
You S; Wood PA; Xiong Y; Kobayashi M; Du-Quiton J; Hrushesky WJ
Breast Cancer Res Treat; 2005 May; 91(1):47-60. PubMed ID: 15868431
[TBL] [Abstract][Full Text] [Related]
10. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.
Hrushesky WJ; Grutsch J; Wood P; Yang X; Oh EY; Ansell C; Kidder S; Ferrans C; Quiton DF; Reynolds J; Du-Quiton J; Levin R; Lis C; Braun D
Integr Cancer Ther; 2009 Dec; 8(4):387-97. PubMed ID: 19926611
[TBL] [Abstract][Full Text] [Related]
11. The timing clockwork of life.
Mazzoccoli G
J Biol Regul Homeost Agents; 2011; 25(1):137-43. PubMed ID: 21382283
[TBL] [Abstract][Full Text] [Related]
12. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
Lévi F
Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
[TBL] [Abstract][Full Text] [Related]
13. Cancer inhibition through circadian reprogramming of tumor transcriptome with meal timing.
Li XM; Delaunay F; Dulong S; Claustrat B; Zampera S; Fujii Y; Teboul M; Beau J; Lévi F
Cancer Res; 2010 Apr; 70(8):3351-60. PubMed ID: 20395208
[TBL] [Abstract][Full Text] [Related]
14. Modeling the circadian clock: from molecular mechanism to physiological disorders.
Leloup JC; Goldbeter A
Bioessays; 2008 Jun; 30(6):590-600. PubMed ID: 18478538
[TBL] [Abstract][Full Text] [Related]
15. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
16. Visualizing jet lag in the mouse suprachiasmatic nucleus and peripheral circadian timing system.
Davidson AJ; Castanon-Cervantes O; Leise TL; Molyneux PC; Harrington ME
Eur J Neurosci; 2009 Jan; 29(1):171-80. PubMed ID: 19032592
[TBL] [Abstract][Full Text] [Related]
17. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Altinok A; Clairambault J; Goldbeter A
Philos Trans A Math Phys Eng Sci; 2008 Oct; 366(1880):3575-98. PubMed ID: 18644767
[TBL] [Abstract][Full Text] [Related]
18. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
19. The role of circadian regulation in cancer.
Gery S; Koeffler HP
Cold Spring Harb Symp Quant Biol; 2007; 72():459-64. PubMed ID: 18419305
[TBL] [Abstract][Full Text] [Related]
20. The circadian clock: pacemaker and tumour suppressor.
Fu L; Lee CC
Nat Rev Cancer; 2003 May; 3(5):350-61. PubMed ID: 12724733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
